CD45 congenic bone marrow transplantation: Evidence for T cell-mediated immunity

Stem Cells

Volumn 22, Issue 6, 2004, Pages 1039-1048

  Xu, Hong ^a   Exner, Beate G ^b   Chilton, Paula M ^a   Schanie, Carrie ^a   Ildstad, Suzanne T ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Chimerism; Congenic bone marrow transplantation; Hematopoietic microenvironment; Niche; Nonmyeloablative conditioning CD45

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ALLOIMMUNITY; ANIMAL CELL; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELLULAR IMMUNITY; CHIMERA; CONGENIC STRAIN; EFFECTOR CELL; GRAFT VERSUS HOST REACTION; IMMUNE RESPONSE; IMMUNOREACTIVITY; NONHUMAN; RECIPIENT; T LYMPHOCYTE ACTIVATION; WHOLE BODY RADIATION; WILD TYPE;

ANIMALIA;

EID: 8644238296     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.22-6-1039     Document Type: Article

References (32)

1. Cobbold SP, Martin G, Qin S et al. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 1986;323:164-166.
2. Cobbold SP, Martin G, Waldmann H. Monoclonal antibodies for the prevention of graft-versus-host disease and marrow graft rejection: the depletion of T-cell subsets in vitro and in vivo. Transplantation 1986;42:239-247.
3. Colson YL, Wren SM, Schuchert MJ et al. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers. J Immunol 1995;155: 4179-4188.
4. Colson YL, Li H, Boggs SS et al. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach. J Immunol 1996;157:2820-2829.
5. Wood ML, Monoco AP. Models of specific unresponsiveness to tissue allografts in anti-lymphocyte serum (ALS) treated mice. Transplant Proc 1978;10:379-387.
6. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 1989;169:493-502.
7. Ito H, Takeuchi Y, Shaffer J et al. Local irradiation enhances congenic donor pluripotent hematopoietic stem cell engraftment similarly in irradiated and nonirradiated sites. Blood 2004;103:1949-1954.
8. van Os R, de Haan G, Ito H et al. The balance among immune suppression, stem cell ablation, competition, and engraftment. Blood 2004;103:2859.
9. Stewart FM, Zhong S, Wuu J et al. Lymphohematopoietic engraftment in minimally myeloablated hosts. Blood 1998; 91:3681-3687.
10. + cells in the recipient hematopoietic environment mediate resistance to engraftment of allogeneic donor bone marrow. J Immunol 2002;168:1636-1643.
11. Xu H, Chilton PM, Huang Y et al. Production of donor T cells is critical for induction of donor-specific tolerance and maintenance of chimerism. J Immunol 2004;172:1463-1471.
12. + cells permits engraftment of bone marrow stem cells and tolerance induction with minimal conditioning. Surgery 1997;122:221-227.
13. Mapara MY, Pelot M, Zhao G et al. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance. Biol Blood Marrow Transplant 2001;7:646-655.
14. Kraus AB, Shaffer J, Toh HC et al. Early host CD8 T-cell recovery and sensitized anti-donor interleukin-2-producing and cytotoxic T-cell responses associated with marrow graft rejection following nonmyeloablative allogeneic bone marrow transplantation. Exp Hematol 2003;31:609-621.
15. + T cells with a mouse MHC-restricted TCR in pig thymus grafts. J Immunol 1998;161: 1320-1326.
16. Sykes M, Chester CH, Sundt TM et al. Effect of T-cell depletion in radiation bone marrow chimeras, III: characterization of allogeneic bone marrow cell populations that increase allogeneic chimerism independently of graft versus host disease in mixed marrow recipients. J Immunol 1989;143:3503-3511.
17. Tomita Y, Sachs DH, Sykes M. Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow. Blood 1994;83:939-948.
18. Wright DE, Wagers AJ, Gulati AP et al. Physiological migration of hematopoietic stem and progenitor cells. Science 2001;294:1933-1936.
19. Uchida N, Tsukamoto A, He D et al. High doses of purified stem cells cause early hematopoietic recovery in syngeneic and allogeneic hosts. J Clin Invest 1998;101:961-966.
20. van Os R, Sheridan TM, Robinson S et al. Immunogenicity of Ly5 (CD45)-antigens hampers long-term engraftment following minimal conditioning in a murine bone marrow transplantation model. STEM CELLS 2001;19:80-87.
21. + T cells play a nonredundant role in the rejection of heart allografts in mice. Surgery 1999;126:121-126.
22. + T cells and NK cells in irradiated mice. J Immunol 1995;155:3742-3749.
23. Ildstad ST, Wren SM, Boggs SS et al. Cross-species bone marrow transplantation: evidence for tolerance induction, stem cell engraftment, and maturation of T lymphocytes in a xenogeneic stromal environment (Rat → Mouse). J Exp Med 1991;174:467-478.
24. + cells in the generation of killer activity. J Exp Med 1975;141:1390-1399.
25. Stewart FM, Zhong S, Lambert JF et al. Host marrow stem cell potential and engraftability at varying times after low-dose whole-body irradiation. Blood 2001;98:1246-1251.
26. Blomberg M, Rao S, Reilly J et al. Repetitive bone marrow transplantation in nonmyeloablated recipients. Exp Hematol 1998;26:320-324.
27. Quesenberry PJ, Crittenden RB, Lowry P et al. In vitro and in vivo studies of stromal niches. Blood Cells 1994;20:97-104.
28. Down JD, Tarbell NJ, Thames HD et al. Syngeneic and allogeneic bone marrow engraftment after total body irradiation: dependence on dose, dose rate, and fractionation. Blood 1991;77:661-669.
29. Saxe DF, Boggs SS, Boggs DR. Transplantation of chromosomally marked syngeneic marrow cells into mice not subjected to hematopoietic stem cell depletion. Exp Hematol 1984;12:277-283.
30. Wu DD, Keating A. Hematopoietic stem cells engraft in untreated transplant recipients. Exp Hematol 1993;21:251-256.
31. Micklem HS, Clarke CM, Evans EP et al. Fate of chromosome-marked mouse bone marrow cells transfused into normal syngeneic recipients. Transplantation 1968;6:299-302.
32. Rao SS, Peters SO, Crittenden RB et al. Stem cell transplantation in the normal nonmyeloablated host: relationship between cell dose, schedule, and engraftment. Exp Hematol 1997;25:114-121.